Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease

Author(s): Mohthash Musambil, Khalid Al-Rubeaan*, Sara Al-Qasim, Dhekra Al Naqeb, Abdulrahman Al-Soghayer

Journal Name: Current Diabetes Reviews

Volume 16 , Issue 6 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Introduction: Hypertriglyceridemia (HTG) is one of the most common metabolic disorders leading to pancreatitis and cardiovascular disease. HTG develops mostly due to impaired metabolism of triglyceride-rich lipoproteins. Although monogenic types of HTG exist, most reported cases are polygenic in nature.

Aim: This review article is focused on the classification of Primary HTG and the genetic factors behind its development with the aim of providing clinicians a useful tool for early detection of the disease in order to administer proper and effective treatment.

Discussion: HTG is often characterized by a complex phenotype resulting from interactions between genetic and environmental factors. In many instances, the complexity, perplexing causes, and classification of HTG make it difficult for clinicians to properly diagnose and manage the disorder. Better availability of information on its pathophysiology, genetic factors involved, environmental causes, and their interactions could help in understanding such complex disorders and could support its effective diagnosis and treatment.

Conclusion: The current review has summarized the case definition, epidemiology, pathophysiology, clinical presentation, classification, associated genetic factors, and scope of genetic screening in the diagnosis of primary HTG.

Keywords: Classification of hypertriglyceridemia, familial hypertriglyceridemia, genetics of HTG, hypertriglyceridemia, primary hypertriglyceridemia.

[1]
Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007; 176(8): 1113-20.
[http://dx.doi.org/10.1503/cmaj.060963] [PMID: 17420495]
[2]
Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 2009; 10(2): 109-21.
[http://dx.doi.org/10.1038/nrg2481] [PMID: 19139765]
[3]
Lewis GF, Xiao C, Hegele RA. Hypertriglyceridemia in the genomic era: a new paradigm. Endocr Rev 2015; 36(1): 131-47.
[http://dx.doi.org/10.1210/er.2014-1062] [PMID: 25554923]
[4]
Brahm A, Hegele RA. Hypertriglyceridemia. Nutrients 2013; 5(3): 981-1001.
[http://dx.doi.org/10.3390/nu5030981] [PMID: 23525082]
[5]
Hegele RA, Ginsberg HN, Chapman MJ, et al. European Atherosclerosis Society Consensus Panel.The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2014; 2(8): 655-66.
[http://dx.doi.org/10.1016/S2213-8587(13)70191-8] [PMID: 24731657]
[6]
Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease. Circ Res 2016; 118(4): 547-63.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306249] [PMID: 26892957]
[7]
Hodis HN, Mack WJ, Krauss RM, Alaupovic P. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol 1999; 22(6)(Suppl.): II15-20.
[http://dx.doi.org/10.1002/clc.4960221404] [PMID: 10376192]
[8]
Negoi I, Paun S, Sartelli M, et al. Hypertriglyceridemia-induced acute pancreatitis: a systematic review of the literature. J Acute Dis 2017; 6(1): 1-5.
[http://dx.doi.org/10.12980/jad.6.2017JADWEB-2016-0058]
[9]
Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol 2014; 48(3): 195-203.
[http://dx.doi.org/10.1097/01.mcg.0000436438.60145.5a] [PMID: 24172179]
[10]
Pejic RN, Lee DT. Hypertriglyceridemia. J Am Board Fam Med 2006; 19(3): 310-6.
[http://dx.doi.org/10.3122/jabfm.19.3.310] [PMID: 16672684]
[11]
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356-9.
[http://dx.doi.org/10.1001/jama.287.3.356] [PMID: 11790215]
[12]
Reiner Z, Catapano AL, De Backer G, et al. European Association for Cardiovascular Prevention & Rehabilitation.ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees.ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769-818.
[http://dx.doi.org/10.1093/eurheartj/ehr158] [PMID: 21712404]
[13]
Catapano AL, Reiner Z, De Backer G, et al. Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees.ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217(Suppl. 1): S1-S44.
[http://dx.doi.org/10.1016/j.atherosclerosis.2011.06.012] [PMID: 21723445]
[14]
Berglund L, Brunzell JD, Goldberg AC, et al. Endocrine society.Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97(9): 2969-89.
[http://dx.doi.org/10.1210/jc.2011-3213] [PMID: 22962670]
[15]
Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25)(Suppl. 2): S1-S45.
[http://dx.doi.org/10.1161/01.cir.0000437738.63853.7a] [PMID: 24222016]
[16]
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.
[http://dx.doi.org/10.1001/jama.285.19.2486] [PMID: 11368702]
[17]
Nordestgaard BG, Langsted A, Mora S, et al. European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative.Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016; 37(25): 1944-58.
[http://dx.doi.org/10.1093/eurheartj/ehw152] [PMID: 27122601]
[18]
Miller M, Stone NJ, Ballantyne C, et al. American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism.Council on Arteriosclerosis, Thrombosis and Vascular Biology.Council on Cardiovascular Nursing.Council on the Kidney in Cardiovascular Disease.Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123(20): 2292-333.
[http://dx.doi.org/10.1161/CIR.0b013e3182160726] [PMID: 21502576]
[19]
Kelly GS. Seasonal variations of selected cardiovascular risk factors. Altern Med Rev 2005; 10(4): 307-20.
[PMID: 16366739]
[20]
Myers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989; 9(1): 105-35.
[http://dx.doi.org/10.1016/S0272-2712(18)30645-0] [PMID: 2538292]
[21]
Gulmez O. Hypertriglyceridemia: a practical review artical for assessment and treatment. Journal of Chronic Diseases and Management 2017; 2(2): 1012.
[22]
Goussault Y, Turpin E, Neel D, et al. ‘Pseudohypertriglyceridemia’ caused by hyperglycerolemia due to congenital enzyme deficiency. Clin Chim Acta 1982; 123(3): 269-74.
[http://dx.doi.org/10.1016/0009-8981(82)90171-1] [PMID: 6288290]
[23]
Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008; 118(20): 2047-56.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.108.804146] [PMID: 18955664]
[24]
Scordo K, Pickett KACE. Triglycerides: do they matter. Am J Nurs 2017; 117(1): 24-31.
[http://dx.doi.org/10.1097/01.NAJ.0000511539.37103.0b] [PMID: 28030403]
[25]
Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2011; 57(3): 482-9.
[http://dx.doi.org/10.1373/clinchem.2010.157164] [PMID: 21189274]
[26]
Guerin M, Egger P, Soudant C, et al. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state. J Lipid Res 2002; 43(10): 1652-60.
[http://dx.doi.org/10.1194/jlr.M200135-JLR200] [PMID: 12364549]
[27]
Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298(3): 309-16.
[http://dx.doi.org/10.1001/jama.298.3.309] [PMID: 17635891]
[28]
Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298(3): 299-308.
[http://dx.doi.org/10.1001/jama.298.3.299] [PMID: 17635890]
[29]
Bansal N, Cruickshank JK, McElduff P, Durrington PN. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol 2005; 16(4): 400-8.
[http://dx.doi.org/10.1097/01.mol.0000174154.61307.16] [PMID: 15990588]
[30]
Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998; 27(6): 879-90.
[http://dx.doi.org/10.1006/pmed.1998.0376] [PMID: 9922071]
[31]
Carroll MD, Lacher DA, Sorlie PD. Trends in serum lipids and lipoproteins of adults 1960-2002. J Vasc Surg 2006; 43(3): 639.
[http://dx.doi.org/10.1016/j.jvs.2006.02.009]
[32]
Reed RG, Kris-Etherton P, Stewart PW, Pearson TA. DELTA (Dietary Effects on Lipoproteins and Thrombogenic Activity) Investigators.Variation of lipids and lipoproteins in premenopausal women compared with men and postmenopausal women. Metabolism 2000; 49(9): 1101-5.
[http://dx.doi.org/10.1053/meta.2000.8603] [PMID: 11016887]
[33]
Herrera E, Amusquivar E, López-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006; 65(Suppl. 3): 59-64.
[PMID: 16612115]
[34]
Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88(6): 2404-11.
[http://dx.doi.org/10.1210/jc.2003-030242] [PMID: 12788835]
[35]
Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997; 27(4): 322-6.
[http://dx.doi.org/10.1046/j.1365-2362.1997.1160662.x] [PMID: 9134381]
[36]
Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29(6): 1263-8.
[http://dx.doi.org/10.2337/dc06-0062] [PMID: 16732006]
[37]
Ferdinand KC. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 2006; 97(2A): 12A-9A.
[http://dx.doi.org/10.1016/j.amjcard.2005.11.011] [PMID: 16442932]
[38]
Haffner SM, D’Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996; 45(6): 742-8.
[http://dx.doi.org/10.2337/diab.45.6.742] [PMID: 8635647]
[39]
Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290(2): 199-206.
[http://dx.doi.org/10.1001/jama.290.2.199] [PMID: 12851274]
[40]
Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291(23): 2847-50.
[http://dx.doi.org/10.1001/jama.291.23.2847] [PMID: 15199035]
[41]
Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 2000; 49(6): 1042-8.
[http://dx.doi.org/10.2337/diabetes.49.6.1042] [PMID: 10866058]
[42]
Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008; 196(2): 696-703.
[http://dx.doi.org/10.1016/j.atherosclerosis.2006.12.018] [PMID: 17254586]
[43]
Metcalf PA, Sharrett AR, Folsom AR, et al. African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1998; 148(8): 750-60.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a009696] [PMID: 9786230]
[44]
Morrison JA, Khoury P, Mellies M, Kelly K, Horvitz R, Glueck CJ. Lipid and lipoprotein distributions in black adults. The Cincinnati Lipid Research Clinic’s Princeton School Study. JAMA 1981; 245(9): 939-42.
[http://dx.doi.org/10.1001/jama.1981.03310340029022] [PMID: 7463698]
[45]
Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and whites with non-insulin-dependent diabetes in the US population. Circulation 1994; 90(3): 1185-93.
[http://dx.doi.org/10.1161/01.CIR.90.3.1185] [PMID: 8087927]
[46]
Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 2005; 54(7): 902-9.
[http://dx.doi.org/10.1016/j.metabol.2005.03.001] [PMID: 15988699]
[47]
Sundquist J, Winkleby MA. Cardiovascular risk factors in Mexican American adults: a transcultural analysis of NHANES III, 1988-1994. Am J Public Health 1999; 89(5): 723-30.
[http://dx.doi.org/10.2105/AJPH.89.5.723] [PMID: 10224985]
[48]
Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation 2006; 113(25): e924-9.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.583815] [PMID: 16801466]
[49]
Karthikeyan G, Teo KK, Islam S, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol 2009; 53(3): 244-53.
[http://dx.doi.org/10.1016/j.jacc.2008.09.041] [PMID: 19147041]
[50]
Hegele RA, Pollex RL. Hypertriglyceridemia: phenomics and genomics. Mol Cell Biochem 2009; 326(1-2): 35-43.
[http://dx.doi.org/10.1007/s11010-008-0005-1] [PMID: 19130180]
[51]
Al Azkawi H, Alalwan I. Two siblings with familial chylomicronemia syndrome: disease course and effectiveness of early treatment. Case Rep Med 2010; 2010807434
[http://dx.doi.org/10.1155/2010/807434] [PMID: 21209733]
[52]
Fredrickson DS, Lees RS. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321-7.
[http://dx.doi.org/10.1161/01.CIR.31.3.321] [PMID: 14262568]
[53]
Shah AS, Wilson DP. Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents 2000.https://www.ncbi.nlm.nih.gov/books/NBK395571/
[54]
Ferns G, Keti V, Griffin B. Investigation and management of hypertriglyceridaemia. J Clin Pathol 2008; 61(11): 1174-83.
[http://dx.doi.org/10.1136/jcp.2008.055756] [PMID: 18955574]
[55]
Soutar AK, Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2007; 4(4): 214-25.
[http://dx.doi.org/10.1038/ncpcardio0836] [PMID: 17380167]
[56]
Online Mendelian Inheritance OMIM. www.omim.org/2017
[57]
Santamarina-Fojo S. The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 1998; 27(3): 551-567, viii.
[http://dx.doi.org/10.1016/S0889-8529(05)70025-6 ] [PMID: 9785052]
[58]
Lee JC, Lusis AJ, Pajukanta P. Familial combined hyperlipidemia: upstream transcription factor 1 and beyond. Curr Opin Lipidol 2006; 17(2): 101-9.
[http://dx.doi.org/10.1097/01.mol.0000217890.54875.13] [PMID: 16531745]
[59]
Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994; 120(12): 1026-36.
[http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00009] [PMID: 8185134]
[60]
Fredrickson DS. Phenotyping. On reaching base camp (1950-1975). Circulation 1993; 87(4)(Suppl.): III1-III15.
[PMID: 8462175]
[61]
Shilpa SV, Vishwanath P, Suma KB, Upadya UB. An interesting case of type IV hyperlipoproteinemia in a pregnant woman with gestational diabetes mellitus. Int J Health Allied Sci 2013; 2(1): 40-2.
[http://dx.doi.org/10.4103/2278-344X.110560]
[62]
Chapman MJ, Ginsberg HN, Amarenco P, et al. European Atherosclerosis Society Consensus Panel.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011; 32(11): 1345-61.
[http://dx.doi.org/10.1093/eurheartj/ehr112] [PMID: 21531743]
[63]
Hegele RA, Ban MR, Hsueh N, et al. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hum Mol Genet 2009; 18(21): 4189-94.
[http://dx.doi.org/10.1093/hmg/ddp361] [PMID: 19656773]
[64]
Johansen CT, Wang J, Lanktree MB, et al. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2011; 31(8): 1916-26.
[http://dx.doi.org/10.1161/ATVBAHA.111.226365] [PMID: 21597005]
[65]
Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res 2011; 52(2): 189-206.
[http://dx.doi.org/10.1194/jlr.R009720] [PMID: 21041806]
[66]
Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol 2011; 22(4): 247-53.
[http://dx.doi.org/10.1097/MOL.0b013e3283471972] [PMID: 21519249]
[67]
Johansen CT, Hegele RA. Allelic and phenotypic spectrum of plasma triglycerides. Biochim Biophys Acta 2012; 1821(5): 833-42.
[http://dx.doi.org/10.1016/j.bbalip.2011.10.007] [PMID: 22033228]
[68]
Beil U, Grundy SM, Crouse JR, Zech L. Triglyceride and cholesterol metabolism in primary hypertriglyceridemia. Arteriosclerosis 1982; 2(1): 44-57.
[http://dx.doi.org/10.1161/01.ATV.2.1.44] [PMID: 7059323]
[69]
Rahalkar AR, Giffen F, Har B, et al. Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol 2009; 87(3): 151-60.
[http://dx.doi.org/10.1139/Y09-005] [PMID: 19295657]
[70]
Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989; 9(3): 326-34.
[http://dx.doi.org/10.1161/01.ATV.9.3.326] [PMID: 2719595]
[71]
Hegele RA, Breckenridge WC, Cox DW, Maguire GF, Little JA, Connelly PW. Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations. Arterioscler Thromb 1991; 11(5): 1303-9.
[http://dx.doi.org/10.1161/01.ATV.11.5.1303] [PMID: 1911716]
[72]
Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 1997; 96(6): 1737-44.
[http://dx.doi.org/10.1161/01.CIR.96.6.1737] [PMID: 9323055]
[73]
Priore Oliva C, Pisciotta L, Li Volti G, et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2005; 25(2): 411-7.
[http://dx.doi.org/10.1161/01.ATV.0000153087.36428.dd] [PMID: 15591215]
[74]
Willer CJ, Schmidt EM, Sengupta S, et al. Global Lipids Genetics Consortium.Discovery and refinement of loci associated with lipid levels. Nat Genet 2013; 45(11): 1274-83.
[http://dx.doi.org/10.1038/ng.2797] [PMID: 24097068]
[75]
Johansen CT, Hegele RA. The complex genetic basis of plasma triglycerides. Curr Atheroscler Rep 2012; 14(3): 227-34.
[http://dx.doi.org/10.1007/s11883-012-0243-2] [PMID: 22528520]
[76]
Chokshi N, Blumenschein SD, Ahmad Z, Garg A. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia. J Clin Lipidol 2014; 8(3): 287-95.
[http://dx.doi.org/10.1016/j.jacl.2014.02.006] [PMID: 24793350]
[77]
Ewald N, Hardt PD, Kloer HU. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol 2009; 20(6): 497-504.
[http://dx.doi.org/10.1097/MOL.0b013e3283319a1d] [PMID: 19770656]
[78]
Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010; 42(8): 684-7.
[http://dx.doi.org/10.1038/ng.628] [PMID: 20657596]
[79]
De Castro-Orós I, Civeira F, Pueyo MJ, et al. Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia. J Clin Lipidol 2016; 10(4): 790-7.
[http://dx.doi.org/10.1016/j.jacl.2016.02.010] [PMID: 27578109]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 6
Year: 2020
Page: [521 - 531]
Pages: 11
DOI: 10.2174/1573399815666190502164131
Price: $65

Article Metrics

PDF: 34
HTML: 1